Brent Rexer

4PUBLICATIONS
43CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 06, 2025
TREM2 expressing macrophages are not associated with prognostic markers or metabolic syndrome in early stage ER positive breast cancer.

Elysa W Pierro, Guadalupe A Garcia, Violeta M Sanchez

|Jul 08, 2025
Phase Ib Trial of Fulvestrant, Palbociclib, and Erdafitinib, a pan-FGFR Tyrosine Kinase Inhibitor, in HR+/HER2- Metastatic Breast Cancer.

Paula I Gonzalez-Ericsson, Nisha Unni, Komal Jhaveri

|May 17, 2023
A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer.

Jamunarani Veeraraghavan, Carolina Gutierrez, Carmine De Angelis

|Nov 17, 2022
Obesity and metabolic syndrome are associated with short-term endocrine therapy resistance in early ER + breast cancer.

Riley Bergman, Yvonne A Berko, Violeta Sanchez

Pageof 1

Frequent Collaborators

2 joint publications

Paula I Gonzalez-Ericsson

2 joint publications

Violeta Sanchez

2 joint publications

Guadalupe Garcia

1 joint publications

Nisha Unni